Michael S. Cookson, MD, MMHC, presented “A Urologist’s Perspective on Germline Testing” for the Grand Rounds in Urology audience in October, 2019.
How to cite: Cookson, Michael S. “A Urologist’s Perspective on Germline Testing” October, 2019. Accessed Dec 2024. https://grandroundsinurology.com/a-urologists-perspective-on-germline-testing/
A Urologist’s Perspective on Germline Testing – Summary:
Michael S. Cookson, MD, MMHC, stresses that, in the current landscape of increased public awareness and commercial availability of germline testing, urologists must stay informed in order to utilize genetic information for the risk assessment, prevention, and prognosis of prostate cancer, as well as guide treatment selections. Dr. Cookson then reviews the existing guidelines regarding the role of germline testing in managing prostate cancer, including recommendations from the Society of Urologic Oncology, National Comprehensive Cancer Network, and the Philadelphia Prostate Cancer Consensus.
This educational activity is based on a series of lectures on genetic testing for prostate cancer from the 2019 Philadelphia Prostate Cancer Consensus Conference. Further activities from this conference include:
Germline Predisposition for Prostate Cancer Among African American and Other Minorities: What Do We Know?
Molecular Insights into the Germline for Prostate Cancer Initiation, Progression, and Aggressiveness
Prostate Cancer Screening & Genetic Testing: The NCCN Perspective
Integration of Germline Testing in Prostate Cancer Screening
Current Prostate Cancer Genetic Testing Capabilities and Considerations
Current NCCN Recommendations for Prostate Cancer Genetic Testing
The Expanding World of Germline Testing for Prostate Cancer: Genetic Counseling Perspective
The Expanding World of Germline Testing for Prostate Cancer: A Clinical Trials Perspective
ABOUT THE AUTHOR
Michael S. Cookson, MD, MMHC, is Professor and Chairman of the Department of Urology and holds the Donald D. Albers Endowed Chair in Urology at the University of Oklahoma Health Sciences Center in Oklahoma City. He has authored some 240 peer-reviewed journal publications as well as more than 30 chapters of various textbooks, and he is nationally recognized for his outstanding contributions to urologic oncology. Dr. Cookson completed his Urology Residency at the University of Texas, San Antonio, and completed his Urologic Oncology Fellowship at Memorial Sloan-Kettering Cancer Center in New York. From 1998 to 2013, he served as the Vice Chairman of Urologic Surgery and Director of the Urologic Oncology Fellowship Program at Vanderbilt University. Dr. Cookson has devoted much of his academic career to the management of patients with urologic cancers, with a strong emphasis on clinical guidelines, education, and evidenced-based medicine. He was a member of the AUA/ABU Examination Committee for 10 years, serving as Oncology Consultant and Pathology Editor. He also serves on the ABU Oral Examination Committee. He is a Co-Founder of the Oncology Knowledge Assessment Test (OKAT), an SUO-mandated examination. He also served as Chair for the OKAT for 5 years. In 2011, he received the President’s Distinguished Service Award from the SUO for educational contributions. He received the 2018 AUA Presidential Citation for Outstanding Service for his role in the development of the OKAT and as Chair of the Castration-Resistant Prostate Cancer Guidelines Committee at the AUA 2018 Annual Meeting. Dr. Cookson has previously served as a member of the AUA Guidelines on Localized Prostate Cancer Committee. Dr. Cookson is currently serving out the 2019-2020 term as the SUO President.